Cargando…

Evaluation of intracanal acetazolamide in late reimplanted rat teeth

OBJECTIVE: The aim of this study was to evaluate the use of acetazolamide combined with different agents as intracanal medication in late reimplanted rat teeth. MATERIALS AND METHODS: In 100 Wistar rats, divided into 5 groups of 20, one of the following medications was used: Acetazolamide liquid (AL...

Descripción completa

Detalles Bibliográficos
Autores principales: Perin, Camila Paiva, Papalexiou, Vula, Rodrigues Johann, Aline Cristina Batista, Ribeiro Mattos, Natanael Henrique, Westphalen, Fernando Henrique, Ditzel Westphalen, Vânia Portela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727723/
https://www.ncbi.nlm.nih.gov/pubmed/29279664
http://dx.doi.org/10.4103/ejd.ejd_191_17
Descripción
Sumario:OBJECTIVE: The aim of this study was to evaluate the use of acetazolamide combined with different agents as intracanal medication in late reimplanted rat teeth. MATERIALS AND METHODS: In 100 Wistar rats, divided into 5 groups of 20, one of the following medications was used: Acetazolamide liquid (AL); AL with calcium hydroxide powder (ALHC); acetazolamide powder with AL; acetazolamide powder with physiological solution; and calcium hydroxide with physiological solution (control). At 30 and 60 days after reimplantation, the animals were sacrificed, tissues were processed, and cuts were stained with hematoxylin and eosin. An optical microscope was used to determine the following: percentage of inflammatory root resorption (RRI); percentage of substitute root resorption (RRS); and presence of ankylosis. The data obtained was submitted for statistical analysis. RESULTS: Group ALHC had a significantly higher RRS than the control group at 60 days (P = 0.01). Group AL showed significantly less ankylosis than the other groups, including the control, at 30 days. AL showed results similar to those of the control group with respect to RRS. CONCLUSION: Acetazolamide has the potential to be an effective intracanal medication.